Medical review pending · noindex

Procedure comparison

Rezūm vs TURP: Water Vapor or Tissue Resection?

Rezūm and TURP occupy different treatment pathways. Rezūm thermally treats selected tissue with water vapor and improvement develops as tissue changes; TURP removes obstructing tissue during the operation. Compare anesthesia and setting, early symptom flare, catheter planning, speed and degree of relief, ejaculation, retreatment, prostate anatomy and the strength of local follow-up.

Decision-support boundary: This draft does not diagnose obstruction, select a procedure, or tell anyone to stop medication. Inability to urinate, fever with urinary symptoms, heavy bleeding, severe pain or rapidly worsening symptoms need prompt medical attention.

Direct answer

The better option is the one that fits measured anatomy and the outcomes you prioritize after contraindications, clinician experience, evidence limits and the complete recovery pathway are reviewed. Neither side of this comparison is universally superior.

Start by confirming why symptoms are occurring. Lower urinary tract symptoms can reflect prostatic obstruction, bladder dysfunction, infection, urethral narrowing, medicines, neurologic conditions or more than one factor. NIDDK notes that tests help clinicians diagnose urinary problems and determine treatment options. A procedure comparison becomes useful only after that diagnostic work is connected to the actual choice.

Rezūm vs TURP: decision matrix

Decision factorRezūmTURP
InterventionWater-vapor injections ablate selected tissue without immediate resection.Electrosurgical loop removes tissue and creates a channel during surgery.
Symptom timelineEarly swelling can temporarily worsen symptoms; benefit develops over time.Relief may be noticed sooner after postoperative irritation settles, but recovery varies.
Catheter planningOften a prominent part of counseling because of swelling and retention risk.Catheter use is part of the operative pathway and depends on recovery.
Anesthesia and settingMay be offered in a less intensive setting depending on patient and center.Usually performed in an operating-room pathway with anesthesia.
Sexual outcomesOften discussed for patients prioritizing ejaculation, without a guarantee.Ejaculatory change is a central consent issue.
DurabilityFive-year randomized-study follow-up is available; retreatment still must be discussed.Long-standing clinical experience; durability depends on resection extent and disease progression.

This table describes decision dimensions, not a personalized recommendation. Device labeling, guideline language, techniques and local pathways can change; verify current details with the treating clinicians.

When the first pathway may enter the discussion

  • You accept delayed improvement and an early irritation period.
  • Your anatomy fits water-vapor treatment.
  • A less intensive procedural pathway and ejaculation discussion matter to you.

When the second pathway or another route may fit

  • You and your urologist prioritize immediate tissue removal.
  • The obstruction or complication profile favors resection.
  • You accept a more conventional surgical recovery and sexual tradeoffs.

Do not compare unlike outcomes

Ask whether a study reports symptom score, peak urinary flow, quality of life, catheter independence, adverse events or repeat treatment. Those outcomes are related but not interchangeable. Also check the starting severity, prostate anatomy, exclusions, follow-up duration and how many participants supplied data at the reported time point. A five-year result from a selected trial population is not a guarantee for an individual.

For sexual outcomes, separate erection, ejaculation, orgasm, libido and fertility. A statement that erectile function was stable does not establish that antegrade ejaculation was preserved. For recovery, separate time to discharge, catheter removal, return to work, urinary irritation and full activity. Marketing phrases that collapse these outcomes can make a procedure appear more certain than the evidence supports.

Questions to take to the consultation

  1. How soon might symptoms worsen before improving?
  2. What catheter plan applies to me?
  3. Does my prostate configuration fit Rezūm?
  4. What relief should I reasonably expect from each?
  5. How do retreatment rates compare at similar follow-up?
  6. What sexual outcomes do you record?
  7. Could urinary retention or bladder weakness change the choice?
  8. When would you recommend TURP instead of a MIST?
Useful request: Ask the clinician to mark which facts are known from your testing, which are estimates from published evidence, and which depend on the center’s own protocol. Request written catheter, medication and after-hours instructions before scheduling.

Evidence and review status

This page uses authoritative patient guidance, a professional guideline and procedure-specific clinical evidence where available. It deliberately avoids unsourced prices, universal recovery times and promises of preserved sexual function. It remains excluded from the XML sitemap until a qualified medical reviewer checks every material claim, current device labeling and the final comparison language.

Sources accessed September 21, 2026. A source link does not mean the source endorses UriSmooth or this page.

Frequently asked questions

1. What should I know about steam treatment?

Steam treatment is one decision dimension, not a verdict for Rezūm or TURP. Ask the clinician to connect it to your documented obstruction, baseline symptoms, health history and the center’s technique, then identify what remains uncertain after current evidence is applied.

2. What should I know about immediate tissue removal?

Immediate tissue removal changes what remains after treatment and what information is available later. Ask whether Rezūm or TURP leaves an implant, supplies tissue for examination, or alters future imaging and procedural choices.

3. What should I know about speed of relief?

Speed of relief is one decision dimension, not a verdict for Rezūm or TURP. Ask the clinician to connect it to your documented obstruction, baseline symptoms, health history and the center’s technique, then identify what remains uncertain after current evidence is applied.

4. What should I know about early symptom flare?

Early symptom flare is one decision dimension, not a verdict for Rezūm or TURP. Ask the clinician to connect it to your documented obstruction, baseline symptoms, health history and the center’s technique, then identify what remains uncertain after current evidence is applied.

5. What should I know about catheter use?

Catheter use is part of the practical Rezūm versus TURP decision. Ask whether a catheter is planned, what triggers removal, where a voiding trial occurs and who responds if emptying fails. Your baseline residual urine and bladder function can matter more than a generic average.

6. What should I know about retention?

Retention is part of the practical Rezūm versus TURP decision. Ask whether a catheter is planned, what triggers removal, where a voiding trial occurs and who responds if emptying fails. Your baseline residual urine and bladder function can matter more than a generic average.

7. What should I know about anesthesia?

Anesthesia depends on the exact pathway used for Rezūm or TURP. Request written instructions covering transport, discharge, urinary symptoms, activity limits, after-hours contact and the conditions that delay return to normal activity.

8. What should I know about ejaculation?

Ejaculation must be defined before comparing Rezūm with TURP. Ask what was measured at baseline, whether ejaculation and erection were reported separately, how many patients supplied follow-up, and why your medicines or health conditions may produce a different outcome.

9. What should I know about erections?

Erections must be defined before comparing Rezūm with TURP. Ask what was measured at baseline, whether ejaculation and erection were reported separately, how many patients supplied follow-up, and why your medicines or health conditions may produce a different outcome.

10. What should I know about prostate anatomy?

Prostate anatomy can change whether either side of this comparison is technically suitable. Have the clinician connect current imaging and test findings to Rezūm, TURP and any excluded option; do not infer eligibility from symptoms or an old size estimate alone.

11. What should I know about retreatment?

Retreatment should be compared at the same follow-up interval with the same definition. For Rezūm and TURP, ask for the number treated, number assessed later, repeat-procedure criteria and the treating center’s own follow-up process.

12. What should I know about treatment failure?

Treatment failure should be compared at the same follow-up interval with the same definition. For Rezūm and TURP, ask for the number treated, number assessed later, repeat-procedure criteria and the treating center’s own follow-up process.

Next decision

Return to the BPH procedure decision hub, compare medication versus a procedure, or build a recovery and catheter plan. UriSmooth is not presented as a substitute for evaluation or a procedure.